| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8648124 | Blood Cells, Molecules, and Diseases | 2017 | 7 Pages | 
Abstract
												The antiphospholipid syndrome (APS) is a multisystem autoimmune disease characterized by recurrent fetal loss and thromboembolic events associated with the presence of elevated titres of antiphospholipid antibodies (aPL). The purpose of this review is to summarize what is currently known about the diagnosis and treatment of pediatric APS, to highlight key differences between APS presenting in adults versus children throughout, and to identify areas where future research is needed.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Molecular Biology
												
											Authors
												Dax G. Rumsey, Barry Myones, Patti Massicotte, 
											